TSI's enfinity Receives Informed Ingredient Certification
Better-for-you caffeine metabolite, enfinity, has achieved Informed Ingredient certification. Distributed by TSI Group, enfinity, is considered to be a cleaner, safer, and more effective alternative to caffeine. With its new certification, it is confirmed to be free of impurities and substances that are banned in sports nutrition products. enfinity is a gluten-free, allergen-free, vegetarian and vegan-friendly, kosher and halal certified premium ingredient that is less bitter than caffeine, is easier to formulate with, and offers athletes:
- Energy, focus, and wakeful clarity
- Mental performance management under stress
- Cognitive fatigue reduction
- Neuroprotective cognitive accelerant
- Improved reaction time and reduced mental errors
- Hunger reduction
- Increased caloric expenditure and thermogenesis
- Significantly lessened side effects of caffeine with dramatically reduced toxicity
- More consistent results: eliminates caffeine’s genetic variability, reducing crashes
Cave Pets Launches Regenerative Organic Certified Supplements
Cave Pets is bringing Regenerative Organic Certified (ROC) supplements to natural retailers and grocers across the U.S. Founded by Jordan Rubin and Jason Dewberry, the brand's product line includes Chomps and Treats, Mushroom Powders, Multi Glandular Tablets with Probiotics, Turmeric, and Hemp sourced from their own 4,000 acres of farmland in Tennessee and Missouri using regenerative agriculture practices that rebuild depleted soil health, improve animal welfare and farmworker fairness.
Focused on their social impact, the company will look to collect 2 million (or close to it) pounds of waste from farms and local business partners this year. They will plant one "Million Member Food Forest" of super-food bearing trees, bushes, vines, and shrubs, and continue to support like minded non-profit organizations while donating 1% of all revenue to regenerative agriculture, nutrition and climate health.
NXT USA Launches in Brazil
NXT USA has partnered with Infinity Pharma Brazil to launch Digexin in Brazil under the name Motility. The plant-based digestive health solution was premiered during the Consulfarma Congress event. Made from a unique blend of tender okra pod and winter cherry root extracts, Digexin supports gastrointestinal health, the connection between the Gut-Brain axis, can improve digestion and intestinal transit time, and increase frequency of bowel movements.
"We are thrilled to introduce Digexin as Motility in Brazil, especially at such a prestigious event... Brazil can be a very challenging market for new dietary supplements, but with Infinity Pharma we have found a partner who can open the doors for this unique digestive health supplement to the Brazilian market through their relationships with doctors, pharmacists, and nutritionists," shared Eric Anderson, Managing Director, NXT USA.
Protocol for Life Balance Wins Award
The American Association of Naturopathic Physicians (AANP) has named Protocol for Life Balance (PFLB) its 2024 Corporation of the Year during its AANP National Conference event in Chicago. The award, presented by Dr. Kasra Pournadeali, ND, President of the AANP, was accepted by David Crosby, Practitioner Channel Brand Manager: “We feel closely aligned in our philosophies of natural health, and we look forward to continuing to be a part of the Naturopathic community.”
PFLB, NOW Health Group's practitioner brand, also hosted an event for AANP members to tour and meet the staff and NOW executives at their manufacturing facility in Bloomingdale, IL during the conference on July 12th.
Natural Grocers Supports FDA's Ruling
"While all of us at Natural Grocers appreciate the fact that the FDA has revoked the use of brominated vegetable oil in food products, we knew it was a problematic ingredient from the start. Its only purpose was to impact the functionality of the food, not to benefit consumers by being an ingredient that was good for our health and wellbeing" said Executive Vice President of Natural Grocers, Heather Isely, in response to the FDA's recent ruling against the use of Brominated Vegetable Oil in food.
The largest family-operated organic and natural grocery retailer has made it a point to not carry any products containing brominated vegetable oil (BVO) due to concerns over its harmful effects. On July 2nd, the FDA shared those concerns after it had evaluated the results of studies that were conducted with the help of the National Institutes of Health (NIH) and concluded that the use of BVO in food was no longer considered safe. Chemically modified fats such as BVO have been used throughout the food industry in order to increase the shelf life of products and help produce highly processed foods and commercial soft drinks.
Global Kratom Coalition Celebrates Kratom Milestone
The Global Kratom Coalition is praising the American Herbal Products Association (AHPA) for its inclusion of kratom in its online Botanical Safety Handbook, 2nd edition. The detailed safety information resource used by manufacturers, health professionals, and consumers provides safety details on over 500 species of herbs now including the pharmacological and toxicological profile of kratom.
Kratom's entry includes in depth analysis of its clinical investigations, adverse effects case reports, and information regarding its traditional use in Southeast Asia. "The inclusion of kratom in the AHPA Botanical Safety Handbook not only underscores kratom’s safety profile but also significantly enhances manufacturers', healthcare providers', and consumers' understanding of kratom," said Matthew Lowe, Executive Director of the Global Kratom Coalition.
UNPA Is Now a Member of GRMA
The United Natural Products Alliance (UNPA) has joined the Global Retailer and Manufacturer Alliance (GRMA). With membership consisting of manufacturers, retailers, public health organizations, and certification bodies, the UNPA is the latest trade association to join the GRMA on its mission of providing dietary supplement, cosmetic, and OTC drug market consumers with access to safe and quality products. UNPA President, Loren Israelsen, shared his thoughts on the new partnership, “UNPA played a key role in the early stages of what eventually became the GRMA. It has a proven track record of bringing together the large retailer community to establish quality standards for dietary supplements sold by GRMA member retailers."
IFF Revamps its Shanghai Location
IFF's 16,000 square-meter “Shanghai Creative Center" will be fully operational by the end of August 2024 after undergoing a renovation and expansion project. The new, state-of-the-art facility will become IFF's largest center in Asia and will look to drive the development of innovative solutions across the IFF portfolio in China and the Asian market space. “The Shanghai Creative Center will bring together capabilities across IFF, all in one location, enabling us to improve our delivery of end-to-end solutions for customers in Asia and around the world,” said Erik Fyrwald, IFF Chief Executive Officer.
The new facility will merge technical synergy and sensory exploration all under one roof. With its open-office layout, sensory science center, state-of-the-art labs to encourage creation, design, and product analysis, Scent creative center, and an exclusive fine fragrance area dedicated to perfumery, the company invested its resources into a space that would provide an immersive olfactory experience and comfortably foster perfumers and flavorists creativity.
Cypress Systems is Now Cypress Minerals
Cypress Systems is rebranding as Cypress Minerals. Founded in 1995, the proprietary minerals will continue offering quality, resilient, and organically bound minerals for optimal absorption, advanced performance, and strong nutrition while monitoring, evaluating, and improving its overall quality control process. In addition to maintaining its current product offerings, the company will also preserve its donation initiative, contributing 1% of all sales to global causes supporting women and children.
EpiCor Postbiotic Supports Kid's Immune Health
A clinical study for EpiCor postbiotic providing immune support to children between the ages of 4 and 12 has been published in the journal of Pediatric Research. Conducted by Cargill and KGK Science, the new randomized, double-blind, placebo-controlled research studied 256 Canadian children, between the ages of 4 and 12, during cold and flu season—Sept 2022 through April 2023. Already backed by over 15 published studies, the new research concluded that a daily 500mg dose of EpiCor postbiotic led to:
- For a period lasting 84 days, caregivers of children that had received EpiCor reported statistically significant reductions in cold and flu symptom severity compared to those taking placebo (P<0.05).
- During the same period, participants given EpiCor registered lower severity scores on symptoms like sore throat, muscle aches and pains, during 84 days of supplementation compared to those receiving a placebo supplement. (P≤0.05).
- Supplementation with EpiCor limited the need for traditional cold and flu medication. Children who had received a placebo were nearly two times (1.7) more likely to use prescription or over-the-counter medications over the 84-day period compared to those who had been given EpiCor.
- A daily regiment of 500mg of EpiCor was safe and well tolerated in a population of healthy children ages 4 through 12.
“With a strong history of clinical success, this new research on immune support in children continues to underscore Cargill's unwavering commitment to developing science-backed solutions that aim to positively impact people’s health and wellness across all life stages,” said Dr. Justin Green, Ph.D., Director of Scientific Affairs at Cargill.
Tate & Lyle Shares Updates for 2024/2025
Tate & Lyle provided updates to its shareholders on key topics heading into its new financial year. Amongst the subjects discussed were the company's expected EBITDA growth between 4% and 7% for the year ending March 31, 2025, the integration of Tate & Lyle and CP Kelco, trading updates for the three month period ending on June 30, 2024, and the advancements made on its share buyback program.
With regards to trading:
- Food & Beverage solutions volume are ahead of the comparative period
- Good revenue growth for Sucralose
- Group EBITDA is ahead of the comparative period
Its share buyback program:
- The 215 million pounds on-market share buyback program to return the net cash proceeds from the sale of the remaining interest in Primient to shareholders began on June 20, 2024
- As of July 24th, a total of 6.7 million shares have been purchased through the program for a total cost of 42 million pounds and are being held as treasury shares
The acquisition of CP Kelco:
- Tate & Lyle and CP Kelco entered into an acquisition agreement on June 20, 2024, for a total implied consideration of $1.8 billion US dollars.
- The partnership will provide Tate with a stronger customer offering of its Sweetening and Fortification platforms and their four core categories.
- CP Kelco financial performance for the first half of 2024 has stabilized.
- The need for shareholder votes on significant transactions will no longer apply due to the announcement by the Financial Conduct Authority of new Listing Rules coming into effect on July, 29, 2024.
- The transaction will be completed once there is receipt of regulatory approvals and other customary conditions.
“We have made a good start to the new financial year with trading in line with our expectations. It’s encouraging to see volume momentum across the business, and we continue to expect volume growth to accelerate as the 2025 financial year progresses..." shared Chief Executive, Nick Hampton.
